@article{3cefa2966aa949908fff0a48dcfdfaa0,
title = "Anticholinergic Medications and Cognitive Function in Late Midlife",
keywords = "APOE ϵ4, anticholinergics, cognitive function, late midlife",
author = "Limback-Stokin, {Martin M.} and Janina Krell-Roesch and Kimberly Roesler and Allison Hansen and Stonnington, {Cynthia M.} and M'Hamed Temkit and Caselli, {Richard J.} and Geda, {Yonas E.}",
note = "Funding Information: Received for publication September 8, 2017; accepted January 23, 2018. From the *Translational Neuroscience and Aging Program, Mayo Clinic; Departments of †Psychiatry and Psychology; ‡Health Sciences Research; and §Neurology, Mayo Clinic, Scottsdale, AZ. M.M.L.-S., K.R., and A.H. were summer research interns under the mentorship of Professor Geda at Mayo Clinic, Scottsdale, AZ. Supported by NIH grants: National Institute of Mental Health (K01 MH068351). The project was also supported by the Robert Wood Johnson Foundation, the Edli Foundation (the Hague, the Netherlands), the Arizona Alzheimer{\textquoteright}s Disease Core Center, and the Arizona Alzheimer{\textquoteright}s Research Consortium (P30AG19610). The authors declare no conflicts of interest. Reprints: Yonas E. Geda, MD, MSc, Neurology and Psychiatry, Mayo Clinic, 13400 E. Shea Blvd., Scottsdale, AZ 85259 (e-mail: geda.yonas@mayo.edu). Copyright {\textcopyright} 2018 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2018",
doi = "10.1097/WAD.0000000000000251",
language = "English (US)",
volume = "32",
pages = "262--264",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}